Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (70)
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 • 4,822 citations
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
2004 • 3,278 citations
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
2004 • 2,880 citations
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
2004 • 2,358 citations
Genome-wide association study reveals genetic risk underlying Parkinson's disease
2009 • 1,863 citations
The substantia nigra of the human brain
1999 • 1,598 citations
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 • 1,502 citations
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
2006 • 1,489 citations
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
2008 • 1,422 citations
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
2009 • 1,280 citations
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
2005 • 1,172 citations
The vacuolar (H+)-ATPases — nature's most versatile proton pumps
2002 • 1,163 citations
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
2012 • 1,134 citations
Small molecule modulation of Smoothened activity
2002 • 958 citations
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
2006 • 861 citations
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
2010 • 794 citations
Pathogenic Lysosomal Depletion in Parkinson's Disease
2010 • 745 citations
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living
1998 • 630 citations
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
1990 • 621 citations
Microtubule-Based Transport Systems in Neurons: The Roles of Kinesins and Dyneins
2000 • 544 citations
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
2010 • 519 citations
Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells
2009 • 486 citations
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists
2002 • 484 citations
A functionally characterized test set of human induced pluripotent stem cells
2011 • 478 citations
Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36
2001 • 473 citations
Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease
2010 • 422 citations
The Regulation and Physiology of Mitochondrial Proton Leak
2011 • 419 citations
Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases
1993 • 415 citations
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
2009 • 410 citations
A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease
2007 • 389 citations
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
2010 • 362 citations
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
2005 • 362 citations
Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells
2011 • 358 citations
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy
2009 • 354 citations
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
2009 • 317 citations
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
2010 • 286 citations
Genetic Analysis of Pathways to Parkinson Disease
2010 • 267 citations
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
2004 • 262 citations
Novel PINK1 mutations in early-onset parkinsonism
2005 • 226 citations
Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts
2011 • 226 citations
CD15, CD24, and CD29 Define a Surface Biomarker Code for Neural Lineage Differentiation of Stem Cells
2009 • 224 citations
Biochemical and pathological characterization of Lrrk2
2006 • 223 citations
RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
2008 • 218 citations
Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization
2010 • 214 citations
Leucine‐rich repeat kinase 2 phosphorylates brain tubulin‐beta isoforms and modulates microtubule stability – a point of convergence in Parkinsonian neurodegeneration?
2009 • 213 citations
Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid
2010 • 209 citations
Clinical features ofLRRK2-associated Parkinson's disease in central Norway
2005 • 186 citations
Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons
2004 • 171 citations
Parkinson's disease: insights from pathways
2010 • 161 citations
Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities
2009 • 152 citations
Stem Cells and Drug Discovery: The Beginning of a New Era?
2008 • 146 citations
Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease
2006 • 136 citations
1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C
2007 • 134 citations
Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients
2010 • 122 citations
Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
2008 • 109 citations
Pluripotent Stem Cells and Disease Modeling
2009 • 107 citations
Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations
2006 • 99 citations
The c‐Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK‐ERK and Akt‐independent mechanism
2004 • 93 citations
Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach
2011 • 77 citations
Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions
2007 • 68 citations
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations
2004 • 66 citations
Stimulation of glutamate receptors in cultured hippocampal neurons causes Ca2+-dependent mitochondrial contraction
2009 • 54 citations
Genetic analysis of LRRK2 mutations in patients with Parkinson disease
2006 • 53 citations
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations
2007 • 52 citations
Bafilomycin A1 activates respiration of neuronal cells via uncoupling associated with flickering depolarization of mitochondria
2010 • 47 citations
Development of Histocompatible Primate‐Induced Pluripotent Stem Cells for Neural Transplantation
2011 • 45 citations
The curious case of phenocopies in families with genetic Parkinson's disease
2011 • 41 citations
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis
2007 • 31 citations
Examining Braak's hypothesis by imaging Parkinson's disease
2010 • 27 citations
Clinical and demographic characteristics of PINK1 mutation carriers-A meta-analysis
2010 • 20 citations